RxDoctor Payments Data

Viachaslau Barodka, MD

Anesthesiology · Philadelphia, PANPI 1851418594

Payments from drug & device makers

What this record shows

AstraZeneca accounts for 73.4% of it on its own, with 5 other manufacturers making up the rest. 2024 is the largest year on record at $1,757, more than ten times the $38 reported in 2019. Among anesthesiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,402in general payments, 2019–2025

Across 31 payments — averaging $109.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Edwards Lifesciences$289
  • Hemosonics LLC$287
  • BD$129
  • Livanova USA, Inc.$109
  • Abbott$93
$24,824in research payments, 2019–2025

Across 1 payment — averaging $24,824 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$25K

What the payments were for

  • Travel & lodging$1,66149%
  • Food & beverage$1,74051%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca19$2,495
Edwards Lifesciences3$289
Hemosonics LLC3$287
BD1$129
Livanova USA, Inc.1$109
Abbott4$93

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,402 in reported general payments places this provider in the 95th percentile of 2,015 anesthesiology providers in Pennsylvania.

See all anesthesiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$18,567
Medicare patients
31
Services billed
87

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →